4//SEC Filing
A2A Pharmaceuticals, Inc. 4
Accession 0001859061-22-000002
CIK 0001840439other
Filed
Aug 18, 8:00 PM ET
Accepted
Aug 19, 6:56 AM ET
Size
4.9 KB
Accession
0001859061-22-000002
Insider Transaction Report
Form 4
A2A Pharmaceuticals, Inc.
10% Owner
Transactions
- Purchase
Common Stock
2022-08-16$13.87/sh−30,684$425,648→ 4,300,000 total
Footnotes (1)
- [F1]Shares were sold in multiple transaction in a range of prices from 13.65 to 14.01 and an average price of 13.872. Details of the specific trades are available upon request
Documents
Issuer
Biomea Fusion, Inc.
CIK 0001840439
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001859061
Filing Metadata
- Form type
- 4
- Filed
- Aug 18, 8:00 PM ET
- Accepted
- Aug 19, 6:56 AM ET
- Size
- 4.9 KB